Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Elective Spinal Fusion Surgery

Clinical trial NCT00327379 · TERMINATED

Trial details

NCT number: NCT00327379
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Blood Loss, Surgical Postoperative Hemorrhage

Start date: 2006-02-27
Primary completion: 2007-03-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.